Upgrade to SI Premium - Free Trial

Sapiens Reports Third Quarter 2020 Financial Results

November 5, 2020 6:55 AM

HOLON, Israel, Nov. 5, 2020 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, and a member of the Formula Group (NASDAQ: FORTY) (TASE: FORT), today announced its financial results for the third quarter ended September 30, 2020.

Summary Results for Third Quarter 2020 (USD in millions, except per share data)

GAAP

Non-GAAP

September 30, 2020

September 30, 2019

% Change

September 30, 2020

September 30, 2019

% Change

Revenue

$97.6

$82.6

18.2%

$98.0

$82.6

18.5%

Gross Profit

$40.1

$33.3

20.3%

$44.2

$36.7

20.4%

Gross Margin

41.0%

40.3%

70 bps

45.1%

44.4%

70 bps

Operating Income

$12.1

$10.1

19.6%

$17.9

$13.5

32.0%

Operating Margin

12.4%

12.2%

20 bps

18.2%

16.4%

180 bps

Net Income (*)

$9.3

$7.4

25.9%

$13.7

$10.4

32.0%

Diluted EPS

$0.18

$0.15

20.0%

$0.27

$0.21

28.6%

(*) Attributable to Sapiens' shareholders.

"Sapiens delivered strong execution across key geographies and product lines to grow third quarter non-GAAP revenue by 18.5%, fueled by outstanding strategic performance in Europe and North America and leveraging existing customer relationships to upsell products and services. Non-GAAP Operating margin increased to a record of 18.2%, an increase of 180 basis points year-over-year," said Roni Al-Dor, Sapiens president and CEO.

  • Lately our products received excellent recognition from the analysts and research community across both Life and P&C, and in North America and Europe:
  • In Europe, we have been recognized as Leaders in the 2 Gartner Magic Quadrant for policy administration and insurance platform for both our Life and P&C solutions

In North America, we have received the Excellent award by Celent in the Life New Business and Underwriting report "Our outlook for 2020 has improved despite COVID-19. We continue to sign new business and increase our revenue from existing customers. In addition, the Delphi acquisition enhances our position as a leading solutions provider in the MPL market in North America. As such, we are raising our 2020 revenue guidance range," concluded Roni Al-Dor. "Our revised 2020 non-GAAP revenue range is now $381 million to $383 million, as compared to our prior range of $376 million to $381 million., we are also increasing the range of our non-GAAP operating margin for 2020 to 17.6% to 17.7% from prior range of 16.5% to 16.9%."

Quarterly Results Conference Call

Management will host a conference call and webcast on November 5, 20202 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-888-668-9141 ; International: +972-3-918-0609; UK: 0-800-917-9141.

The live webcast of the call can be viewed on Sapiens' website at https://www.sapiens.com/investor-relations/ir-events-presentations/.

If you are unable to join live, a replay of the call will be accessible until November 14, 2020, as follows: North America: 1-877-456-0009; International: 972-3-9255901. A recorded version of the webcast will also be available via the Sapiens website for three months at the same location.

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back payments related to investment in the new campus in India, cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

About Sapiens

Sapiens International Corporation empowers insurers to succeed in an evolving industry. The company offers digital software platforms, solutions and services for the property and casualty, life, pension and annuity, reinsurance, financial and compliance, workers' compensation and financial markets. With more than 35 years of experience delivering to over 500 organizations globally, Sapiens has a proven ability to satisfy customers' core, data and digital requirements. For more information: www.sapiens.com

Forward Looking Statements

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2019, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

Investors and Media Contact Brett MassManaging PartnerHayden IRPhone: +1 646-536-7331Email: [email protected]

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME U.S. dollars in thousands (except per share amounts)

Three months ended

Nine months ended

September 30

September 30

2020

2019

2020

2019

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue

97,645

82,643

281,242

238,959

Cost of revenue

57,567

49,316

166,641

144,371

Gross profit

40,078

33,327

114,601

94,588

Operating expenses:

Research and development, net

10,375

9,445

30,229

27,145

Selling, marketing, general and administrative

17,606

13,767

49,594

39,797

Total operating expenses

27,981

23,212

79,823

66,942

Operating income

12,097

10,115

34,778

27,646

Financial and other expenses, net

1,042

261

2,593

1,749

Taxes on income

1,520

2,349

6,430

6,350

Net income

9,535

7,505

25,755

19,547

Attributable to non-controlling interest

196

87

299

134

Net income attributable to Sapiens' shareholders

9,339

7,418

25,456

19,413

Basic earnings per share

0.19

0.15

0.51

0.39

Diluted earnings per share

0.18

0.15

0.50

0.38

Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

50,625

50,027

50,367

50,005

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

51,581

50,742

51,280

50,534

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME U.S. dollars in thousands (except per share amounts)

Three months ended

Nine months ended

September 30

September 30

2020

2019

2020

2019

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue

97,968

82,643

281,565

238,959

Cost of revenue

53,762

45,931

155,668

134,349

Gross profit

44,206

36,712

125,897

104,610

Operating expenses:

Research and development, net

11,881

10,986

34,423

31,648

Selling, marketing, general and administrative

14,466

12,196

42,218

35,101

Total operating expenses

26,347

23,182

76,641

66,749

Operating income

17,859

13,530

49,256

37,861

Financial and other expenses, net

1,042

261

2,593

1,749

Taxes on income

2,875

2,770

8,866

7,635

Net income

13,942

10,499

37,797

28,477

Attributable to non-controlling interest

196

87

299

134

Net income attributable to Sapiens' shareholders

13,746

10,412

37,498

28,343

Basic earnings per share

0.27

0.21

0.74

0.57

Diluted earnings per share

0.27

0.21

0.73

0.56

Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

50,625

50,027

50,367

50,005

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

51,581

50,742

51,280

50,534

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES RECONCILIATION OF GAAP TO NON-GAAP RESULTSU.S. dollars in thousands (except per share amounts)

Three months ended

Nine months ended

September 30,

September 30,

2020

2019

2020

2019

(unaudited)

(unaudited)

(unaudited)

(unaudited)

GAAP revenue

97,645

82,643

281,242

238,959

Valuation adjustment on acquired deferred revenue

323

-

323

-

Non-GAAP revenue

97,968

82,643

281,565

238,959

GAAP gross profit

40,078

33,327

114,601

94,588

Revenue adjustment

323

-

323

-

Amortization of capitalized software

1,600

1,438

4,627

4,169

Amortization of other intangible assets

2,205

1,947

6,346

5,853

Non-GAAP gross profit

44,206

36,712

125,897

104,610

GAAP operating income

12,097

10,115

34,778

27,646

Gross profit adjustments

4,128

3,385

11,296

10,022

Capitalization of software development

(1,506)

(1,541)

(4,194)

(4,503)

Amortization of other intangible assets

825

539

2,112

1,614

Stock-based compensation

1,361

382

2,747

1,123

Acquisition-related costs *)

954

650

2,517

1,959

Non-GAAP operating income

17,859

13,530

49,256

37,861

GAAP net income attributable to Sapiens'shareholders

9,339

7,418

25,456

19,413

Operating income adjustments

5,762

3,415

14,478

10,215

Taxes on income

(1,355)

(421)

(2,436)

(1,285)

Non-GAAP net income attributable toSapiens' shareholders

13,746

10,412

37,498

28,343

(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Summary of NON-GAAP Financial Information U.S. dollars in thousands (except per share amounts)

Q3 2020

Q2 2020

Q1 2020

Q4 2019

Q3 2019

Revenues

97,968

93,063

90,534

86,715

82,643

Gross profit

44,206

41,900

39,791

38,402

36,712

Operating income

17,859

16,783

14,614

14,345

13,530

Net income to Sapiens' shareholders

13,746

13,340

10,412

10,553

10,412

Adjusted EBITDA

19,010

17,854

15,724

15,271

14,523

Basic earnings per share

0.27

0.27

0.21

0.21

0.21

Diluted earnings per share

0.27

0.26

0.20

0.21

0.21

Non-GAAP Revenues by Geographic Breakdown U.S. dollars in thousands

Q3 2020

Q2 2020

Q1 2020

Q4 2019

Q3 2019

North America

49,979

46,610

44,567

41,787

44,413

Europe

42,394

41,030

40,232

37,504

30,273

Rest of the world

5,595

5,423

5,735

7,424

7,957

Total

97,968

93,063

90,534

86,715

82,643

Adjusted Free Cash-Flow U.S. dollars in thousands

Q3 2020

Q2 2020

Q1 2020

Q4 2019

Q3 2019

Cash-flow from operating activities

16,705

14,761

5,759

21,429

18,671

Increase in capitalized software development costs

(1,506)

(1,251)

(1,437)

(1,162)

(1,541)

Capital expenditures

(963)

(393)

(552)

(2,456)

(973)

Capital expenditures related to new campus in India

-

-

-

-

(6,325)

Free cash-flow

14,236

13,117

3,770

17,811

9,832

Capital expenditures related to new campus in India

-

-

-

-

6,325

Cash payments attributed to acquisition-related costs(*) (**)

242

1,562

737

200

100

Adjusted free cash-flow

14,478

14,679

4,507

18,011

16,257

(*) Included in cash-flow from operating activities

(**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Adjusted EBITDA Calculation U.S. dollars in thousands

Three months ended

Nine months ended

September 30

September 30

2020

2019

2020

2019

GAAP operating profit

12,097

10,115

34,778

27,646

Non-GAAP adjustments:

Valuation adjustment on acquired deferred revenue

323

-

323

-

Amortization of capitalized software

1,600

1,438

4,627

4,169

Amortization of other intangible assets

3,030

2,486

8,458

7,467

Capitalization of software development

(1,506)

(1,541)

(4,194)

(4,503)

Stock-based compensation

1,361

382

2,747

1,123

Compensation related to acquisition and acquisition-related costs

954

650

2,517

1,959

Non-GAAP operating profit

17,859

13,530

49,256

37,861

Depreciation

1,151

993

3,332

2,544

Adjusted EBITDA

19,010

14,523

52,588

40,405

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS U.S. dollars in thousands

September 30,

December 31,

2020

2019

(unaudited)

(unaudited)

ASSETS

CURRENT ASSETS

Cash and cash equivalents

131,667

66,295

Trade receivables, net and unbilled receivables

63,805

50,221

Investment in restricted deposit

-

22,890

Other receivables and prepaid expenses

10,399

7,817

Total current assets

205,871

147,223

LONG-TERM ASSETS

Property and equipment, net

16,744

16,601

Severance pay fund

5,377

5,106

Goodwill and intangible assets, net

266,696

228,691

Operating lease right-of-use assets

49,300

49,539

Other long-term assets

6,095

5,261

Total long-term assets

344,212

305,198

TOTAL ASSETS

550,083

452,421

LIABILITIES AND EQUITY

CURRENT LIABILITIES

Trade payables

5,306

5,107

Current maturities of Series B Debentures

19,796

9,898

Accrued expenses and other liabilities

67,465

60,574

Current maturities of operating lease liabilities

9,558

8,312

Deferred revenue

26,450

21,021

Total current liabilities

128,575

104,912

LONG-TERM LIABILITIES

Series B Debentures, net of current maturities

98,681

58,850

Deferred tax liabilities

6,395

5,082

Other long-term liabilities

10,847

8,321

Long-term operating lease liabilities

44,934

43,394

Accrued severance pay

7,274

6,364

Total long-term liabilities

168,131

122,011

REDEEMABLE NON-CONTROLLING INTEREST

477

-

EQUITY

252,900

225,498

TOTAL LIABILITIES AND EQUITY

550,083

452,421

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES CONSOLIDATED STATEMENT OF CASH FLOW U.S. dollars in thousands

For the Nine months ended June 30,

2020

2019

(unaudited)

(unaudited)

Cash flows from operating activities:

Net income

25,755

19,547

Reconciliation of net income to net cash provided by operating

activities:

Depreciation and amortization

16,417

14,180

Accretion of discount on Series B Debentures

91

124

Capital gain from sale of property and equipment

4

(129)

Stock-based compensation related to options issued to employees

2,747

1,123

Net changes in operating assets and liabilities, net of amount acquired:

Trade receivables, net and unbilled receivables

(10,225)

3,642

Deferred tax assets, net

(391)

(2,664)

Other operating assets

3,653

1,425

Trade payables

(778)

(1,534)

Other operating liabilities

(294)

4,562

Deferred revenues

(194)

4,419

Accrued severance pay, net

440

33

Net cash provided by operating activities

37,225

44,728

Cash flows from investing activities:

Purchase of property and equipment

(1,908)

(9,018)

Investment in deposit

(379)

(1,119)

Proceeds from sale of property and equipment

12

821

Proceeds from restricted deposit used for completed acquisition

22,890

-

Payments for business acquisitions, net of cash acquired

(35,395)

(1,572)

Capitalized software development costs

(4,194)

(4,503)

Net cash used in investing activities

(18,974)

(15,391)

Cash flows from financing activities:

Proceeds from employee stock options exercised

4,919

435

Distribution of dividend

(7,044)

(10,362)

Repayment of Series B Debenture

(9,898)

(9,898)

Issuance of Series B Debentures

60,386

-

Receipt of short-term loan

20,000

-

Repayment of loan

(20,000)

(4)

Payment of contingent considerations

(538)

(120)

Dividend to non-controlling interest

-

(66)

Net cash provided by (used in) financing activities

47,825

(20,015)

Effect of exchange rate changes on cash and cash equivalents

(704)

(812)

Increase in cash and cash equivalents

65,372

8,510

Cash and cash equivalents at the beginning of period

66,295

64,628

Cash and cash equivalents at the end of period

131,667

73,138

Debentures Covenants

As of September 30, 2020, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

Covenant 1

  • Target shareholders' equity (excluding minority interest): above $120 million.
  • Actual shareholders' equity equal to $251 million.

Covenant 2

  • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
  • Actual ratio of net financial indebtedness to net capitalization equal to (5.05)%.

Covenant 3

  • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
  • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (0.18).

In October 2020, the company completed a capital raise of $100M.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/sapiens-reports-third-quarter-2020-financial-results-301167089.html

SOURCE Sapiens International Corporation

Categories

PRNewswire Press Releases

Next Articles